AU2001284645A1 - Quinuclidine-substituted aryl compounds for treatment of disease - Google Patents
Quinuclidine-substituted aryl compounds for treatment of diseaseInfo
- Publication number
- AU2001284645A1 AU2001284645A1 AU2001284645A AU8464501A AU2001284645A1 AU 2001284645 A1 AU2001284645 A1 AU 2001284645A1 AU 2001284645 A AU2001284645 A AU 2001284645A AU 8464501 A AU8464501 A AU 8464501A AU 2001284645 A1 AU2001284645 A1 AU 2001284645A1
- Authority
- AU
- Australia
- Prior art keywords
- quinuclidine
- disease
- treatment
- substituted aryl
- aryl compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22616400P | 2000-08-18 | 2000-08-18 | |
US60226164 | 2000-08-18 | ||
US28495601P | 2001-04-19 | 2001-04-19 | |
US28497101P | 2001-04-19 | 2001-04-19 | |
US28496801P | 2001-04-19 | 2001-04-19 | |
US60284971 | 2001-04-19 | ||
US60284956 | 2001-04-19 | ||
US60284968 | 2001-04-19 | ||
PCT/US2001/021136 WO2002016356A2 (en) | 2000-08-18 | 2001-08-17 | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001284645A1 true AU2001284645A1 (en) | 2002-03-04 |
Family
ID=27499421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001284645A Abandoned AU2001284645A1 (en) | 2000-08-18 | 2001-08-17 | Quinuclidine-substituted aryl compounds for treatment of disease |
Country Status (3)
Country | Link |
---|---|
US (1) | US6492386B2 (en) |
AU (1) | AU2001284645A1 (en) |
WO (1) | WO2002016356A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7214686B2 (en) | 1997-06-30 | 2007-05-08 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
SE0000540D0 (en) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
WO2003032897A2 (en) * | 2001-10-16 | 2003-04-24 | Astrazeneca Ab | Azabicyclic compounds for the treatment of fibromyalgia syndrome |
CN100371714C (en) | 2001-12-14 | 2008-02-27 | 塔加西普特公司 | Methods and compositions for treatment of central nervous system disorders |
DE10164139A1 (en) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-heteroaryl carboxamides |
US7659278B2 (en) * | 2002-02-21 | 2010-02-09 | Aprea Ab | Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases |
WO2004039366A1 (en) * | 2002-11-01 | 2004-05-13 | Pharmacia & Upjohn Company Llc | Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy |
US7238715B2 (en) * | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
ES2293086T3 (en) * | 2002-12-06 | 2008-03-16 | The Feinstein Institute For Medical Research | INFLAMMATION INHIBITION USING COLINERGIC AGONISTS FROM UNION TO ALFA RECEIVER 7. |
US7432280B2 (en) | 2003-06-20 | 2008-10-07 | Eli Lilly And Company | 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake |
US7402592B2 (en) | 2003-10-15 | 2008-07-22 | Targacept, Inc. | Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
EP1751150A2 (en) * | 2004-05-19 | 2007-02-14 | Neurosearch A/S | Novel azabicyclic aryl derivatives |
GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
JP2009506037A (en) | 2005-08-22 | 2009-02-12 | ターガセプト,インコーポレイテッド | Heteroaryl-substituted diazatricycloalkanes, methods for their preparation and methods for their use |
US8316104B2 (en) | 2005-11-15 | 2012-11-20 | California Institute Of Technology | Method and apparatus for collaborative system |
SA08290475B1 (en) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2S,3R)-N-(2-((3-Pyridinyl)Methyl)-1-Azabicyclo[2.2.2]Oct-3-yl)Benzofuran-2-Carboxamide, Novel Salt forms, and Methods of Use Thereof |
CN104193741B (en) | 2007-10-01 | 2016-08-24 | 阿尔法梅根有限责任公司 | Quinuclidine-4-ylmethyl 1H-indole-3-carboxylic acid ester derivant as alpha 7 nicotinic acetylcholine receptor ligands |
PT2254598E (en) | 2008-02-13 | 2013-10-16 | Targacept Inc | Combination of alpha 7 nicotinic agonists and antipsychotics |
US20090318520A1 (en) * | 2008-06-20 | 2009-12-24 | Afecta Pharmaceuticals Drive | Use of isoindoles for the treatment of neurobehavioral disorders |
PL2889033T3 (en) | 2008-11-19 | 2018-10-31 | Forum Pharmaceuticals Inc. | Treatment of negative symptoms of schizophrenia with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
WO2010132423A1 (en) * | 2009-05-11 | 2010-11-18 | Envivo Pharmaceuticals, Inc. | Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors |
MX2012013345A (en) | 2010-05-17 | 2013-02-11 | Envivo Pharmaceuticals Inc | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]th iophene-2-carboxamide hydrochloride monohydrate. |
CN103183625B (en) | 2011-12-28 | 2015-07-08 | 四川大学 | Anti-HIV compound and preparation method and application thereof |
CA2872005A1 (en) | 2012-05-08 | 2013-11-14 | Forum Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
MA37975B2 (en) * | 2012-09-11 | 2021-03-31 | Genzyme Corp | Glucosylceramide synthase inhibitors |
US9434724B2 (en) | 2014-07-11 | 2016-09-06 | Alpharmagen, Llc | Quinuclidines for modulating alpha 7 activity |
US9724340B2 (en) | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
KR20230043024A (en) | 2020-07-24 | 2023-03-30 | 젠자임 코포레이션 | Pharmaceutical composition comprising benglustat |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5237066A (en) * | 1987-02-04 | 1993-08-17 | Delande S.A. | Enantiomers of absolute configuration S of amide derivatives of 3-aminoquinuclidine, the process for preparing them and their application in therapy |
US4863919A (en) * | 1988-02-01 | 1989-09-05 | A. H. Robins Company, Incorporated | Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes |
EP0353371A1 (en) * | 1988-08-04 | 1990-02-07 | Synthelabo | Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides |
GB9027487D0 (en) * | 1990-12-19 | 1991-02-06 | Beecham Group Plc | Pharmaceuticals |
US5741819A (en) * | 1995-06-07 | 1998-04-21 | 3-Dimensional Pharmaceuticals, Inc. | Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
SE9600683D0 (en) * | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
SE9903760D0 (en) * | 1999-10-18 | 1999-10-18 | Astra Ab | New compounds |
SE9904176D0 (en) * | 1999-11-18 | 1999-11-18 | Astra Ab | New use |
SE0000540D0 (en) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
-
2001
- 2001-08-17 AU AU2001284645A patent/AU2001284645A1/en not_active Abandoned
- 2001-08-17 US US09/932,325 patent/US6492386B2/en not_active Expired - Fee Related
- 2001-08-17 WO PCT/US2001/021136 patent/WO2002016356A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US6492386B2 (en) | 2002-12-10 |
US20020052389A1 (en) | 2002-05-02 |
WO2002016356A3 (en) | 2002-05-16 |
WO2002016356A2 (en) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001282873A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
AU2001284645A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
AU2001282875A1 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease | |
AU2001284646A1 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease | |
HUP0203803A3 (en) | Pyridopyrimidinone derivatives for treatment of neurodegenerative disease | |
IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
AU2935200A (en) | Compounds for the treatment of obesity | |
AU2001276860A1 (en) | Medicaments for chemotherapeutic treatment of disease | |
AU2003217275A1 (en) | Azabicyclic compounds for the treatment of disease | |
GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
AU2002227958A1 (en) | Use of moulding compounds for producing treatment devices | |
AU7622000A (en) | Compounds for the treatment of viral-mediated diseases | |
AU2002210385A1 (en) | Furazanyl-triazole derivates for the treatment of diseases | |
AU2000258650A1 (en) | 2-piperidone compounds for the treatment of cancer | |
AU2002312897A1 (en) | Drugs for the treatment of the alzheimer disease | |
AU2002322481A1 (en) | Use of r-nsaid compounds for anti-hiv treatment | |
AU8322401A (en) | Indole compounds useful for the treatment of cancer | |
AU2002303145A1 (en) | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases | |
AU2002322263A1 (en) | Eglin c based drugs for treatment of disease | |
AUPR610501A0 (en) | Treatment of parasitic disease | |
AU3004000A (en) | Methods for the treatment of apolipoprotein e related diseases | |
AU2003299101A1 (en) | Compounds for the treatment of alzheimer's disease | |
AU2002364774A1 (en) | Ilk inhibitors for the treatment of renal disease | |
AU1405001A (en) | Treatment of diseases |